Aspersecosteroid B
C28H40O9 — CID 156581692
Data last refreshed: (MolForge compound catalog, from PubChem)
About Aspersecosteroid B
Aspersecosteroid B (PubChem CID 156581692) has the molecular formula C28H40O9 and a molecular weight of 520.62 g/mol. Its IUPAC name is (1R,3R,4S,5R,6S,7R,9S,11R,15R,17S,20R)-11,15,17-trihydroxy-7-[(1R,2R)-1-hydroxy-2,3-dimethylbutyl]-4,6,20-trimethyl-2,8,21-trioxahexacyclo[13.5.1.13,20.01,12.04,11.05,9]docos-12-ene-14,22-dione.
Molecular Properties
| Compound Name | Aspersecosteroid B |
|---|---|
| PubChem CID | 156581692 |
| Molecular Formula | C28H40O9 |
| Molecular Weight | 520.62 g/mol |
| Exact Mass | 520.27 |
| IUPAC Name | (1R,3R,4S,5R,6S,7R,9S,11R,15R,17S,20R)-11,15,17-trihydroxy-7-[(1R,2R)-1-hydroxy-2,3-dimethylbutyl]-4,6,20-trimethyl-2,8,21-trioxahexacyclo[13.5.1.13,20.01,12.04,11.05,9]docos-12-ene-14,22-dione |
| SMILES | CC(C)[C@@H](C)[C@@H](O)[C@@H]1O[C@H]2C[C@]3(O)C4=CC(=O)[C@@]5(O)C[C@@H](O)CC[C@]6(C)C(=O)[C@H](O[C@@]46O5)[C@]3(C)[C@H]2[C@@H]1C |
| InChI | InChI=1S/C28H40O9/c1-12(2)13(3)20(31)21-14(4)19-16(35-21)11-26(33)17-9-18(30)27(34)10-15(29)7-8-24(5)22(32)23(25(19,26)6)36-28(17,24)37-27/h9,12-16,19-21,23,29,31,33-34H,7-8,10-11H2,1-6H3/t13-,14+,15+,16+,19+,20-,21-,23+,24-,25+,26+,27-,28-/m1/s1 |
| InChIKey | WGQMKMDPTKIRQA-QCSRYMEUSA-N |
| XLogP | 1.24 |
| TPSA | 142.75 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 520.62 |
| LogP ≤ 5 | 1.24 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156581692 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.